Lana Medical Co. reported a net profit rise of 5% to SAR 3.2 million for the first half of 2024, from SAR 3.1 million a year earlier.
Item | 6m 2023 | 6m 2024 | Change |
---|---|---|---|
Revenues | 21.67 | 33.66 | 55.3 % |
Gross Income | 8.09 | 11.47 | 41.8 % |
Operating Income | 3.84 | 4.20 | 9.4 % |
Net Income | 3.06 | 3.22 | 5.3 % |
Average Shares | 3.00 | 3.60 | 20.0 % |
EPS (Riyals) | 1.02 | 0.89 | (12.3 %) |
The rise in the six-month net profit was driven by a 55.31% leap year-on-year (YoY) in revenue, as the company boosted its market share. Revenue was propelled by government projects.
Item | H1 2023 | H1 2024 | Change |
---|---|---|---|
Revenues | 21.67 | 33.66 | 55.3 % |
Gross Income | 8.09 | 11.47 | 41.8 % |
Operating Income | 3.84 | 4.20 | 9.4 % |
Net Income | 3.06 | 3.22 | 5.3 % |
Average Shares | 3.00 | 3.60 | 20.0 % |
EPS (Riyals) | 1.02 | 0.89 | (12.3 %) |
Item | H2 2023 | H1 2024 | Change |
---|---|---|---|
Revenues | 26.96 | 33.66 | 24.9 % |
Gross Income | 12.06 | 11.47 | (4.9 %) |
Operating Income | 0.73 | 4.20 | 473.2 % |
Net Income | (0.05) | 3.22 | 6659.1 % |
Average Shares | 3.60 | 3.60 | - |
EPS (Riyals) | (0.01) | 0.89 | 6659.1 % |
Total shareholders’ equity, no minority interest, rose to SAR 71.27 million as of June 30, 2024, compared to SAR 50.48 million a year earlier.
Historical Data |
|||
Period |
Revenue (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
2023 |
|||
H1 |
21.67 |
3.06 |
1.02 |
H2 |
26.96 |
(0.05) |
(0.01) |
2024 |
|||
H1 |
33.66 |
3.22 |
0.89 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}